31 patents currently held
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2028. from the record
Of the 10 now held by other companies, 8 name Beckman Coulter Inc. as their current owner, and 2 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
4
Ending by 2030
Sep 2028
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2034 · High confidence
Also notable
Ends Mar 2034 · High confidence
Also notable
Ends Mar 2034 · High confidence
Dynamic Range Extension Systems and Methods for Particle Analysis in Blood Samples
US 10,429,292
Cited by 30 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2034.
Autofocus Systems and Methods for Particle Analysis in Blood Samples
US 10,705,008
Cited by 21 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2034.
Sheath Fluid Systems and Methods for Particle Analysis in Blood Samples
US 9,316,635
The most cited patent in this portfolio, cited by 37 later US patents, top 10% of utility patents granted in 2016 in our data. Protection runs to 2034.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 9, 2027The maintenance fee for Flowcell Systems and Methods for Particle Analysis in Blood Samples (US 10,345,217) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
- 1 fee due Mar 24, 2027The maintenance fee for Systems and Methods for Imaging Fluid Samples (US 10,422,738) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
- 2 fees due Apr 1 to 22, 2027 · next Apr 1
- 1 fee due Jul 12, 2027The maintenance fee for Homogeneous Analyte Detection (US 9,234,890) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
- 2 fees due Aug 13 to 20, 2027 · next Aug 13
- 1 fee due Sep 8, 2027The maintenance fee for Method and Composition for Staining and Sample Processing (US 9,279,750) comes due Sep 8, 2027. Unpaid by Mar 8, 2028, it lapses early.
- 3 fees due Oct 2 to 26, 2027 · next Oct 2
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
What they patent
The 5 largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Dynamic Range Extension Systems and Methods for Particle Analysis in Blood Samples | 4 in force | to May 2035 |
| Autofocus Systems and Methods for Particle Analysis in Blood Samples | 4 in force | to Feb 2035 |
| Sheath Fluid Systems and Methods for Particle Analysis in Blood Samples | 4 in force | to Mar 2034 |
| System and Method of Classification of Biological Particles | 3 in force | to Oct 2037 |
| Flowcell Systems and Methods for Particle Analysis in Blood Samples | 3 in force | to Mar 2034 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,702,172 | Particle Extraction for Automatic Flow Microscope In force · High confidence | In force | High confidence | |
| US 9,234,890 | Homogeneous Analyte Detection In force · High confidence | In force | High confidence | |
| US 7,822,276 | Method and Apparatus for Analyzing Body Fluids In force · High confidence | In force | High confidence | |
| US 7,947,186 | Centrifugal Device and Method for Fluid Component Separation In force · High confidence | In force | High confidence | |
| US 11,903,926 | Non-Hormonal Treatment Of Hot Flashes held by Iris International Pharma, LLC In force · Medium confidence | In force | Medium confidence | |
| US 12,734,151 | Non-Hormonal Treatment Of Hot Flashes held by Iris International Pharma, LLC In force · Medium confidence | In force | Medium confidence | |
| US 9,279,750 | Method and Composition for Staining and Sample Processing In force · High confidence | In force | High confidence | |
| US 9,316,635 | Sheath Fluid Systems and Methods for Particle Analysis in Blood Samples In force · High confidence | In force | High confidence | |
| US 9,322,752 | Flowcell Systems and Methods for Particle Analysis in Blood Samples In force · High confidence | In force | High confidence | |
| US 9,470,618 | Sheath Fluid Systems and Methods for Particle Analysis in Blood Samples In force · High confidence | In force | High confidence |
Also on record, not counted in the 31: 10 patents in force now held by others · 18 patents ended · 13 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.